Inhibrx, Inc. Contracts & Agreements

71 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Option Agreement, dated August 19, 2019, by and between the Registrant and Chiesi Farmaceutici S.p.A
Inhibrx, Inc.
Biotechnology
2019
Termination Agreement, dated February
Termination Agreements
Inhibrx, Inc.
2024
Agreement and Plan of Merger, dated as of January 22, 2024, by and among Inhibrx, Inc., Aventis Inc., and Art Acquisition Sub, Inc
Merger Agreements
Inhibrx, Inc.
2024
Separation and Distribution Agreement, dated as of January 22, 2024, by and among Inhibrx, Inc., Ibex SpinCo, Inc., and Aventis Inc
Separation Agreements
Inhibrx, Inc.
2024
Form of Agreement to Pre-Funded Warrant to Purchase Common Stock and Securities Purchase Agreement, dated January 22, 2024, by and between Inhibrx, Inc. and each holder of the...
Warrant Agreements
Inhibrx, Inc.
2024
Amendment to Warrants to Purchase Stock, dated January 22, 2024, by and between Inhibrx, Inc. and Oxford Finance LLC
Stock Agreements
Inhibrx, Inc.
2024
Inhibrx, Inc. Clawback Policy
Inhibrx, Inc.
2023
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Inhibrx, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Inhibrx, Inc.
2023
Third Amended and Restated Executive Employment Agreement, effective as of January 1, 2023, by and between the Company and Mark Lappe
Employment Agreements
Inhibrx, Inc.
2022
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2023, by and between the Company and Kelly Deck
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2022
Fifth Amendment to Loan and Security Agreement, dated June 15, 2022, by and between the Company and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2022
Separation Letter Agreement, effective as of February 1, 2022, by and between the Registrant and Klaus Wagner, M.D., Ph.D
Separation Agreements
Inhibrx, Inc.
Biotechnology
2022
Fourth Amendment to Loan and Security Agreement, dated February 18, 2022, by and between the Company and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
Biotechnology
DE
2022
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Mark Lappe
Employment Agreements
Inhibrx, Inc.
2021
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Klaus Wagner, M.D., Ph.D
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2021
Second Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Brendan Eckelman, Ph.D
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2021
Amended and Restated Executive Employment Agreement, effective as of January 1, 2022, by and between the Company and Kelly Deck
Employment Agreements
Inhibrx, Inc.
2021
Third Amendment to Loan and Security Agreement, dated June 18, 2021, by and between the Company and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2021
Description of the Registrants Securities
Inhibrx, Inc.
2021
First Amendment to Loan and Security Agreement, dated November 12, 2020, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Inhibrx, Inc.
2020
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Mark Lappe
Employment Agreements
Inhibrx, Inc.
2020
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Klaus Wagner, M.D., Ph.D
Employment Agreements
Inhibrx, Inc.
2020
Amended and Restated Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Brendan Eckelman, Ph.D
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2020
Executive Employment Agreement, effective as of August 7, 2020, by and between the Registrant and Kelly Deck
Employment Agreements
Inhibrx, Inc.
2020
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
DE
2020
Second Amended and Restated Investors Rights Agreement, dated April 6, 2020, by and among the Registrant and the investors named therein
Investor Rights Agreements
Inhibrx, Inc.
2020
Second Amendment to Right of First Refusal and Co-Sale Agreement, dated April 6, 2020, by and among the Registrant and the investors named therein
Inhibrx, Inc.
Biotechnology
CA
2020
Form of Warrant to Purchase Stock by and between the Registrant and Oxford Finance LLC
Warrant Agreements
Inhibrx, Inc.
Biotechnology
NY
2020
Form of Indemnification Agreement
Indemnification Agreements
Inhibrx, Inc.
Biotechnology
DE
2020
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
2020
Amendment to Convertible Promissory Note, dated April 6, 2020, by and between the Registrant and DRAGSA 50 LLC
Note Agreements
Inhibrx, Inc.
2020
Form of Convertible Promissory Note, dated April 6, 2020, by and between the Registrant and each of DRAGSA 50 LLC and certain other investors
Note Agreements
Inhibrx, Inc.
2020
Option and License Agreement, dated June 9, 2020, by and between the Registrant and bluebird bio, Inc
License Agreements
Inhibrx, Inc.
Biotechnology
DE
2020
Loan and Security Agreement, dated July 15, 2020, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2020
Amendment No. 1 to Amended and Restated Master Services Agreement, dated December 11, 2019, by and between the Registrant and WuXi Biologics (Hong Kong) Limited
Services Agreements
Inhibrx, Inc.
Biotechnology
2020
Non-Employee Director Compensation Policy
Compensation Agreements
Inhibrx, Inc.
Biotechnology
2020
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
DE
2019
Amendment to Inhibrx, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect)
Bonus & Incentive Agreements
Inhibrx, Inc.
2019
Form of Common Stock Certificate
Stock Agreements
Inhibrx, Inc.
Biotechnology
2019
Amended and Restated Investors Rights Agreement, dated May 20, 2019, by and between the Registrant and the investors named therein
Investor Rights Agreements
Inhibrx, Inc.
2019
Right of First Refusal and Co-Sale Agreement, dated April 30, 2018, by and between the Registrant and the investors named therein
Inhibrx, Inc.
2019
First Amendment to Right of First Refusal and Co-Sale Agreement, dated May 20, 2019, by and between the Registrant and the investors named therein
Inhibrx, Inc.
2019
Form of Indemnification Agreement
Indemnification Agreements
Inhibrx, Inc.
2019
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Mark Lappe
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Klaus Wagner, M.D., Ph.D
Employment Agreements
Inhibrx, Inc.
2019
Executive Employment Agreement, effective as of January 1, 2019, by and between the Registrant and Brendan Eckelman, Ph.D
Employment Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
DE
2019
Form of Stock Option Grant Notice under the 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect)
Bonus & Incentive Agreements
Inhibrx, Inc.
2019
Form of Restricted Stock Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan (currently in effect)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
DE
2019
Form of Stock Option Grant Notice under the Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
Form of Restricted Stock Agreement under the Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan (to be effective upon completion of this offering)
Bonus & Incentive Agreements
Inhibrx, Inc.
2019
License Agreement, dated July 1, 2013, by and between INBRX 103, LLC and Celgene Corporation
License Agreements
Inhibrx, Inc.
2019
Amendment to License Agreement, dated November 23, 2018, by and among the Registrant, INBRX 103, LLC and Celgene Corporation
License Agreements
Inhibrx, Inc.
2019
License Agreement, dated June 21, 2017, by and between the Registrant and Hangzhou Just Biotherapeutics Co., Ltd
License Agreements
Inhibrx, Inc.
Biotechnology
NY
2019
Technical Services Agreement, dated March 19, 2018, by and between the Registrant and Hangzhou Just Biotherapeutics Co., Ltd
Services Agreements
Inhibrx, Inc.
Biotechnology
NY
2019
Technical Services Agreement, dated October 6, 2018, by and between the Registrant and Hangzhou Just Biotherapeutics Co., Ltd
Services Agreements
Inhibrx, Inc.
2019
License Agreement, dated February 28, 2018, by and between the Registrant and Elpiscience Biopharmaceuticals, Inc
License Agreements
Inhibrx, Inc.
2019
License Agreement, dated April 30, 2018, by and between the Registrant and Elpiscience Biopharmaceuticals, Inc
License Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
License Agreement, dated December 20, 2018, by and between the Registrant and bluebird bio, Inc
License Agreements
Inhibrx, Inc.
Biotechnology
NY
2019
Loan and Security Agreement, dated March 31, 2015, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2019
First Amendment, Waiver and Consent to Loan and Security Agreement, dated August 15, 2016, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2019
Second Amendment to Loan and Security Agreement, dated December 22, 2016, by and between the Registrant and Oxford Finance LLC
Loan Agreements
Inhibrx, Inc.
2019
Consent and Third Amendment to Loan and Security Agreement, dated April 30, 2018, by and among the Registrant, Oxford Finance LLC and the Lenders listed therein
Loan Agreements
Inhibrx, Inc.
Biotechnology
CA
2019
Amended and Restated Master Services Agreement, dated August 28, 2018, by and between the Registrant and WuXi Biologics (Hong Kong) Limited
Services Agreements
Inhibrx, Inc.
2019
First Amendment to Lease, dated May 21, 2019, by and between the Registrant and HCP TPSP, LLC
Lease Agreements
Inhibrx, Inc.
2019
Convertible Promissory Note, dated May 20, 2019, by and between the Registrant and DRAGSA 50 LLC
Note Agreements
Inhibrx, Inc.
Biotechnology
DE
2019
Option Agreement, dated May 29, 2019, by and between the Registrant and Chiesi Farmaceutici S.p.A
Inhibrx, Inc.
Biotechnology
NY
2019
Lease Agreement, dated September 8, 2017, by and between the Registrant and HCP TPSP, LLC
Lease Agreements
Inhibrx, Inc.
2019